Lifestyle and Environment Environmental Exposures
RRM Academy Synopsis
Early fetal androgen block caused hypospadias in male rats
In a rat experiment, an early-window anti-androgen caused hypospadias in about 6 out of 10 male rats. A late-window one caused none. Pregnant rats received an anti-androgen or testosterone in timed fetal windows. Among exposed males, a shorter anogenital distance was linked to worse hypospadias and more undescended testes.
Key Findings
- The anti-androgen flutamide, given in the early or middle fetal window, caused hypospadias in 64% and 63% of male rats. Late-window exposure caused neither hypospadias nor cryptorchidism.
- Cryptorchidism, or undescended testes, was induced in male rats only by flutamide exposure that included the early window. Only 7% and 12% of early- and middle-window males had a ventral prostate.
- In flutamide-exposed male rats, a subnormal anogenital distance correlated with the incidence and severity of hypospadias (P < 0.001), cryptorchidism (P < 0.001) and reduced phallus length (r2 = 0.7).
- Female rats given testosterone in the early window formed a prostate and seminal vesicles and reached a male anogenital distance. In females, late-window testosterone had no effect on anogenital distance.
- Based on rat timings, the authors believe the human programming window is likely to be 8–14 weeks of gestation, and they write that it remains to be proven.
Interpretation
This controlled animal experiment randomly assigned 39 pregnant Wistar rats to flutamide, testosterone or vehicle. Dosing covered an early, middle, late or full window in the last week of gestation. Flutamide groups held 8–28 rats from 2–5 litters, and the offspring were examined at set ages. The results describe cause and timing in rats. No humans were studied. The authors suggest that measuring anogenital distance, the span between anus and genitals, in newborn humans could provide a noninvasive indicator of early androgen action.
RRM Context
Restorative reproductive medicine treats male fertility as a root-cause question for the couple. The paper describes hypospadias and cryptorchidism, with low sperm count and testicular cancer, as parts of a hypothesized testicular dysgenesis syndrome. The hypothesized origin is fetal life. A history of such birth conditions adds context to a man's evaluation. The rat timing here offers a developmental hypothesis.
Abstract
Becoming a phenotypic male is ultimately determined by androgen-induced masculinization. Disorders of fetal masculinization, resulting in hypospadias or cryptorchidism, are common, but their cause remains unclear. Together with the adult-onset disorders low sperm count and testicular cancer, they can constitute a testicular dysgenesis syndrome (TDS). Although masculinization is well studied, no unifying concept explains normal male reproductive development and its abnormalities, including TDS. We exposed rat fetuses to either anti-androgens or androgens and showed that masculinization of all reproductive tract tissues was programmed by androgen action during a common fetal programming window. This preceded morphological differentiation, when androgen action was, surprisingly, unnecessary. Only within the programming window did blocking androgen action induce hypospadias and cryptorchidism and altered penile length in male rats, all of which correlated with anogenital distance (AGD). Androgen-driven masculinization of females was also confined to the same programming window. This work has identified in rats a common programming window in which androgen action is essential for normal reproductive tract masculinization and has highlighted that measuring AGD in neonatal humans could provide a noninvasive method to predict neonatal and adult reproductive disorders. Based on the timings in rats, we believe the programming window in humans is likely to be 8-14 weeks of gestation.


